TUCAN (CARD8) genetic variants and inflammatory bowel disease

DPB McGovern, H Butler, T Ahmad, M Paolucci… - Gastroenterology, 2006 - Elsevier
DPB McGovern, H Butler, T Ahmad, M Paolucci, DA Van Heel, K Negoro, P Hysi
Gastroenterology, 2006Elsevier
Background & Aims: The identification of the association between Crohn's disease (CD) and
NOD2 (CARD15) confirmed both the heritability of CD and highlighted the role of the nuclear
factor κB (NFκB) pathway in disease pathogenesis. Other susceptibility loci exist. TUCAN
(CARD8) is located beneath a CD peak of linkage on chromosome 19q. TUCAN is
expressed in the gut and is a negative regulator of NFκB, making it an excellent candidate
gene for gastrointestinal inflammation. Methods: Ten single nucleotide polymorphisms …
Background & Aims
The identification of the association between Crohn’s disease (CD) and NOD2 (CARD15) confirmed both the heritability of CD and highlighted the role of the nuclear factor κB (NFκB) pathway in disease pathogenesis. Other susceptibility loci exist. TUCAN (CARD8) is located beneath a CD peak of linkage on chromosome 19q. TUCAN is expressed in the gut and is a negative regulator of NFκB, making it an excellent candidate gene for gastrointestinal inflammation.
Methods
Ten single nucleotide polymorphisms (SNP) across TUCAN were genotyped in 365 controls, 372 patients with CD, and 373 patients with ulcerative colitis. A diagnostic panel for CD was constructed using smoking status and TUCAN, NOD2, IBD5, NOD1, and TNFSF15 data.
Results
We demonstrate significant association between a TUCAN SNP and CD (OR 1.35, P = .0083). The association was more pronounced with disease affecting sites other than the colon (odds ratio, 1.52) and NOD2-negative CD (odds ratio, 1.50). Combination of these data with smoking and NOD2, IBD5, NOD1, and TNFSF15 status demonstrated very strong associations with CD and high sensitivities (96.3%), specificities (99.4%), and likelihood ratios (12.8) for CD, although further work will be needed before this model can be translated into direct clinical utility.
Conclusions
We have shown an association between a likely functional polymorphism in TUCAN and CD. The combination of these data in a genetic panel suggests that clinicians may soon be able to translate genetic advances into direct benefits for patients.
Elsevier